Marcello Leopoldo

Via Orabona, 4
Bari, 70125, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Journal: Pharmacology & therapeutics

Published: August 26, 2010

5-HT(7) receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009).

5-HT(7) receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009).

Journal: Expert opinion on therapeutic patents

Published: May 19, 2010

Developments in fluorescent probes for receptor research.

Developments in fluorescent probes for receptor research.

Journal: Drug discovery today

Published: November 25, 2008

Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II.

Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II.

Journal: Bioorganic & medicinal chemistry

Published: September 09, 2008

5-HT1A receptor, an old target for new therapeutic agents.

5-HT1A receptor, an old target for new therapeutic agents.

Journal: Current topics in medicinal chemistry

Published: August 12, 2008

Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors.

Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors.

Journal: Bioorganic & medicinal chemistry

Published: March 06, 2007

Synthesis and binding profile of constrained analogues of N-[4-(4-arylpiperazin-1-yl)butyl]-3-methoxybenzamides, a class of potent dopamine D3 receptor ligands.

Synthesis and binding profile of constrained analogues of N-[4-(4-arylpiperazin-1-yl)butyl]-3-methoxybenzamides, a class of potent dopamine D3 receptor ligands.

Journal: The Journal of pharmacy and pharmacology

Published: February 03, 2006

Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D3 receptors.

Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D3 receptors.

Journal: Journal of medicinal chemistry

Published: January 06, 2006

First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.

First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.

Journal: Journal of medicinal chemistry

Published: December 13, 2005

Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.

Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.

Journal: Journal of medicinal chemistry

Published: December 14, 2004

Serotonin(7) receptors (5-HT(7)Rs) and their ligands.

Serotonin(7) receptors (5-HT(7)Rs) and their ligands.

Journal: Current medicinal chemistry

Published: March 23, 2004

Studies on 1-arylpiperazine derivatives with affinity for rat 5-HT7 and 5-HT1A receptors.

Studies on 1-arylpiperazine derivatives with affinity for rat 5-HT7 and 5-HT1A receptors.

Journal: The Journal of pharmacy and pharmacology

Published: March 10, 2004

Showing 1-12 of 13

Last Updated: 09/26/2026